Institut de Cancérologie Lucien Neuwirth

Saint-Priest-en-Jarez 42271

0 studies enrolling now · 6 studies all time

What they study most

Acute Lymphoblastic Leukemia, Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer, Metastatic Breast Cancer, Myelofibrosis, Non-Small-Cell Lung Carcinoma, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis, Secondary School Student in General High School Who Does Not Have a Disability That Does Not Allow a Good Understanding of the Study Requirements

Studies at this site

• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling
• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
• Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer — Completed
• I2S-Health Prevention — Status unconfirmed
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed
• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer — Stopped early